GLP-1s & Meal Replacements: Resource Center

This platform offers medical professionals and physicians exclusive access to advanced resources on GLP-1 medications and meal replacements. It includes webinars led by industry experts, in-depth white papers, and a diverse blog library, all designed to support informed clinical decisions and enhance medical knowledge. Stay informed with the latest research and expert perspectives in this dynamic field.

The Physician’s Guide to GLP-1 Success

View PDF

Webinars

Thriving in a GLP-1 World: How to Keep Your Weight Loss Practice Relevant and Profitable Despite Rising Medication Demand
By Karol Clark, MSN, RN

Fueling Success: Optimizing Nutrition in GLP-1 Agonist Therapy
By Holly F. Lofton, MD

Beyond the Shot (or Pill): Talking with Patients about the Importance of Healthy Dietary Patterns while on GLP-1 Agonist Drugs
By Kristin Kirkpatrick, MS, RDN

Implementing the New Anti-Obesity Medications into a Comprehensive Low Calorie Diet (LCD) Program
By Holly F. Lofton, MD

Tapping into Transformation: The Financial and Health Benefits of Combining Weight Loss Products and Medications
By Karol Clark, MSN, RN

Empowering Sustainable Weight Loss: Integrating Lifestyle and Nutrition for VLCD and GLP-1 Patients
By Katie Chapmon, MS, RD

White Papers

Benefits of Scientifically Formulated Meal Replacements in a GLP-1 Nutrition Plan

The Clinical Importance of Using Meal Replacements with Anti-Obesity Medication

The Efficacy of Meal Replacements for Managing Weight and Jump-Starting Weight Loss in Patients with Obesity

The Crucial Role of Meal Replacements in Enhancing GLP-1 Medication Effects

Blogs

GLP-1 Pills and the Ongoing Importance of Nutrition Support

February 19, 2026
Behavior, Blog, GLP-1, Nutrition, Obesity, Obesity Related Diseases, Obesity Treatment, Patient Management, Quality of Life, Semaglutide

As oral GLP-1 therapies expand, thoughtful nutrition support remains essential for safe, sustainable outcomes.

Can GLP-1 Medications Help Patients with Non-Alcoholic Fatty Liver Disease?

November 25, 2025
Blog, GLP-1, Liver Disease, Obesity, Obesity Related Diseases, Obesity Treatment, Weight Gain

GLP-1 medications have emerged as a possible pharmacological treatment for patients with non-alcoholic fatty liver disease.

A Role for GLP-1 in Treating Hyperphagia and Obesity

October 1, 2025
Behavior, Blog, Exercise, GLP-1, Nutrition, Obesity, Obesity Treatment, Quality of Life, Semaglutide, Stress, Weight Gain

For patients exhibiting clinically clear signs of hyperphagia — such as chronic hunger, frequent snacking, and heightened food-cue reactivity — GLP-1 medications may offer significant relief. However, in addition to pharmacotherapy, a comprehensive treatment approach may be beneficial for these patients.

Evaluating the Effectiveness of GLP-1, Exercise, and Their Combination in Patient Care

September 16, 2025
Behavior, Blog, Exercise, GLP-1, Nutrition, Obesity, Obesity Treatment, Quality of Life

Current thinking suggests that combining GLP-1 medication with exercise may be more effective for weight loss than relying on either approach alone. But is this truly the case?

Are GLP-1 Medications Safe for Long-Term Use in Patients with Type 2 Diabetes?

September 4, 2025
Blog, Diabetes, GLP-1, Nutrition, Obesity, Obesity Treatment, Quality of Life, Type 2 Diabetes

GLP-1 medications are increasingly used for weight loss and glycemic control in adults with obesity and type 2 diabetes, but health care professionals are advised to monitor their safety, especially for long-term use in patients with comorbidities, as well as for cardiovascular outcomes, potential pancreatic cancer risks, and anesthesia-related complications.

Can a GLP-1 Medication Help Treat Binge Eating?

June 25, 2025
Behavior, Behavior, Blog, GLP-1, Meal Replacements, Nutrition, Obesity Related Diseases, Obesity Treatment, Patient Management, Quality of Life, Semaglutide, Social Issues

The use of GLP-1 for a binge eating disorder is evolving as a potentially transformative adjunctive approach for treatment.

Bridging the Competency Gap in Obesity Care: Elevating Behavior Change Counseling

June 10, 2025
Behavior, Blog, GLP-1, Meal Replacements, Nutrition, Obesity Related Diseases, Obesity Treatment, VCLD/LCD Program

While advancements such as GLP-1 medications and bariatric surgery have improved clinical outcomes, a persistent gap remains in the use of behavioral interventions for weight management.